🇫🇷·Jun 12Research
LIKOZAM (Clobazam 1mg/mL suspension buvable) : fin de la dispensation en rétrocession au CHU dès le 12 juin 2026
Publisher
C
CHU de Toulouse
France
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- CHU de Toulouse
- Region
- France
- Scope
- Research
- Published
- June 12, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on chu-toulouse.fr
Leave the platform to read the original full article on the publisher site.
Source: CHU de Toulouse
Scope: Research
Related coverage
More related coverage
Helsinki University Research/2h ago
A Semester with WORK-IT: Reflections from our assistants
NIHR School for Public Health Research/2h ago
Reflections from my PhD: Improving the mental health of young people through early intervention and prevention
KEMRI Kenya/2h ago
Parliamentary Health Committee Backs Increased Investment in KEMRI to Advance Research and Vaccine Development
KEMRI Kenya/2h ago